Patent · US Active

CGRP receptor antagonists

US9637495B2 · kind B2 · utility

1Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2016
Grant dateMay 2, 2017
Priority date—
Expiry dateAug 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a compound of Formula II:or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.